These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 19419253

  • 41. Eprosartan: a review of its use in the management of hypertension.
    Robins GW, Scott LJ.
    Drugs; 2005; 65(16):2355-77. PubMed ID: 16266204
    [Abstract] [Full Text] [Related]

  • 42. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.
    Lüders S.
    Drugs; 2007; 67(7):955-63. PubMed ID: 17488141
    [Abstract] [Full Text] [Related]

  • 43. Potential renoprotective effects of the angiotensin receptor blocker eprosartan: a review of preliminary renal studies.
    Rayner B, Jaeger B, Verboom CN, Pascoe M.
    Cardiovasc J S Afr; 2004; 15(1):32-7. PubMed ID: 14997235
    [Abstract] [Full Text] [Related]

  • 44. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.
    Fuentes B, Ortega-Casarrubios MA, Martínez P, Díez-Tejedor E.
    Cerebrovasc Dis; 2007; 24 Suppl 1():96-106. PubMed ID: 17971644
    [Abstract] [Full Text] [Related]

  • 45. Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy.
    McInnes GT.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S17-20. PubMed ID: 17199214
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Adjustment of antihypertensive therapy to a generic eprosartan preparation. Results of a non-interventional study].
    Nüdling S, Kahner-Gröne S, Köneke D, Marggraf K, Palissa H.
    MMW Fortschr Med; 2010 Oct 14; 152 Suppl 3():96-101. PubMed ID: 21595153
    [No Abstract] [Full Text] [Related]

  • 50. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P.
    MMW Fortschr Med; 2008 Jan 17; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract] [Full Text] [Related]

  • 51. [Stroke prevention. Is there an added value to RAS inhibition?].
    MMW Fortschr Med; 2000 Feb 10; 142(6):62-3. PubMed ID: 10832360
    [No Abstract] [Full Text] [Related]

  • 52. Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.
    Voors AA, van de Wal RM, Hartog JW, Vijn RG, Hummel YM, Plokker TW, van Veldhuisen DJ, Jaarsma W.
    Cardiovasc Drugs Ther; 2010 Feb 10; 24(1):33-40. PubMed ID: 20229056
    [Abstract] [Full Text] [Related]

  • 53. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, Reboldi G.
    Eur Heart J; 2009 Mar 10; 30(6):679-88. PubMed ID: 19168534
    [Abstract] [Full Text] [Related]

  • 54. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K, Miller NH.
    J Am Acad Nurse Pract; 2009 Jan 10; 21(1):66-75. PubMed ID: 19125897
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Angiotensin II inhibition and prevention of atrial fibrillation and stroke.
    Bourassa MG.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):720-1. PubMed ID: 15734616
    [No Abstract] [Full Text] [Related]

  • 57. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.
    Expert Rev Neurother; 2009 Sep 01; 9(9):1413-31. PubMed ID: 19769454
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Transient ischemic attacks: Part II. Treatment.
    Solenski NJ.
    Am Fam Physician; 2004 Apr 01; 69(7):1681-8. PubMed ID: 15086040
    [Abstract] [Full Text] [Related]

  • 60. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
    Oprisiu-Fournier R, Faure S, Mazouz H, Boutitie F, Serot JM, Achard JM, Godefroy O, Hanon O, Temmar M, Albu A, Strandgaard S, Wang J, Black SE, Fournier A.
    Expert Rev Neurother; 2009 Sep 01; 9(9):1289-305. PubMed ID: 19769445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.